LipiFlow is an in-office treatment for dry eye syndrome. LipiFlow is the only FDA- approved device for treating Meibomian Gland Dysfunction. It works by removing gland blockages and restoring gland function. LipiFlow may need to be repeated every year or two depending on the severity of dry eye syndrome, and may require maintenance care at home to prolong the benefits of the treatment. However, for some patients looking to reduce the need for at-home care, the LipiFlow treatment may be repeated more frequently.